Your browser doesn't support javascript.
loading
Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010-2020).
Xirogianni, Athanasia; Marmaras, Nektarios; Georgakopoulou, Theano; Papandreou, Anastasia; Simantirakis, Stelmos; Magaziotou, Ioanna; Eliades, Andreas; Getsi, Vassiliki; Anastasiou-Katsiardani, Anastasia; Staikou, Efi; Markou, Fani; Argyrοpoulou, Athina; Vlachaki, Georgia; Chronopoulou, Genovefa; Pangalis, Anastasia; Liakopoulou, Theodota; Michos, Athanasios; Spoulou, Vassiliki; Lagona, Evaggelia; Panagiotakopoulos, George; Petinaki, Efthymia; Mantadakis, Elpis; Roilides, Emmanuel; Galanakis, Manolis; Papaevangelou, Vana; Tsolia, Maria; Tzanakaki, Georgina.
Afiliação
  • Xirogianni A; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
  • Marmaras N; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
  • Georgakopoulou T; Department of Vaccine Preventable Diseases, National Public Health Organization (NPHO), Athens, Greece.
  • Papandreou A; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
  • Simantirakis S; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
  • Magaziotou I; Department of Vaccine Preventable Diseases, National Public Health Organization (NPHO), Athens, Greece.
  • Eliades A; Dept. of Paediatric Intensive Care Unit, University Hospital of Patras, Greece.
  • Getsi V; Dept. of Paediatrics, (")Hatzikosta" General Hospital, Ioannina, Greece.
  • Anastasiou-Katsiardani A; Dept. of Paediatrics, General Volos Hospital (")Achillopouleio", Greece.
  • Staikou E; Dept. of Microbiology, "Pentelis" Children Hospital, Athens, Greece.
  • Markou F; Dept. of Microbiology, Serres General Hopsital, Serres, Greece.
  • Argyrοpoulou A; Dept. of Clinical Microbiology "Evangelismos" General Hospital, Athens, Greece.
  • Vlachaki G; Dept. of Paediatrics, "Venizeleion" General Hospital, Heraklion, Crete, Greece.
  • Chronopoulou G; Central Labs, Athens EUROCLINIC Group, Athens, Greece.
  • Pangalis A; Central Lab, "Iatriko" Medical Center, Athens, Greece.
  • Liakopoulou T; First Dept. of Paediatrics, "IASO" Children's Hospital, Athens, Greece.
  • Michos A; First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Spoulou V; First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Lagona E; Dept. of Paediatrics, "MITERA" General Hospital, Athens, Greece.
  • Panagiotakopoulos G; Department of Vaccine Preventable Diseases, National Public Health Organization (NPHO), Athens, Greece.
  • Petinaki E; Dept. of Microbiology, Dept. of Microbiology, Medical School, University of Thessaly, Larissa, Greece.
  • Mantadakis E; Dept. of Paediatrics, Faculty of Medicine, Democritus University of Thrace, University General Hospital, Alexandroupolis, Greece.
  • Roilides E; 3rd Dept. of Paediatrics, School of Medicine, Aristotle University, and Hippokration General Hospital, Thessaloniki, Greece.
  • Galanakis M; Paediatric Infectious Diseases Unit, Heraklion University Hospital, University of Crete, Heraklion, Greece.
  • Papaevangelou V; Third Department of Pediatrics, National and Kapodistrian University of Athens, University General Hospital "ATTIKON", Athens, Greece.
  • Tsolia M; Second Dept. of Pediatrics, Medical School, National and Kapodistrian University of Athens, "A&P Kyriakou" Children's Hospital, Athens, Greece.
  • Tzanakaki G; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece. Electronic address: gtzanakaki@uniwa.gr.
Vaccine ; 40(34): 5079-5087, 2022 08 12.
Article em En | MEDLINE | ID: mdl-35871868
ABSTRACT

BACKGROUND:

As Greece is a country which has introduced the 13-valent pneumococcal conjugate vaccine (PCV13) both in the infant and in the adult immunization programs, the aim of the study was to investigate age-specific and serotype-specific trends of pneumococcal meningitis over an 11-year period (2010-2020). MATERIALS AND

METHODS:

Data are reported from pneumococcal meningitis cases [notified to the National Public Health Organization (NPHO)], with clinical samples and bacterial isolates sent for pneumococcal identification and serotyping at the National Meningitis Reference Laboratory (NMRL). Pneumococcal identification was performed directly on clinical samples or bacterial isolates by multiplex PCR (mPCR) assay, while serotyping was carried out by application of the Capsular Sequence Typing (CST) method with the combination of single tube PCR assays.

RESULTS:

A total of 427 pneumococcal meningitis cases were notified to the NPHO between 2010 and 2020. Among those, 405 (94.8%) were microbiologically confirmed, while samples from 273 patients were sent to the NMRL for identification and/or further typing. The annual notification rate peaked at 0.47/100,000 in 2016 and since then has been decreasing. The incidence was highest in infants and in older adults. Pneumococcal serotypes were identified in 260/273 (95.2%) cases, where clinical samples were sent to the NMRL. The most prevalent serotypes (≥5%) were 3, 19A, 23B, 15B/C, 11A/D, 23A, 22F. During the study period there has been a decrease of PCV13 serotypes combined with an increase of non-PCV13 serotypes (p = 0.0045).

CONCLUSIONS:

This is the first study to report serotypes for pneumococcal meningitis across all ages in the post-PCV13 era in Greece. There is a need to enhance surveillance, by close monitoring of the emerging serotypes and the impact of vaccination programs. Higher-valency PCVs may help to improve the coverage of pneumococcal disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Meningite Pneumocócica Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Meningite Pneumocócica Tipo de estudo: Observational_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article